Literature DB >> 25608538

[Predictive validity of the Braden Scale for pressure ulcer risk: a meta-analysis].

Seong Hi Park1, Yu Sun Park2.   

Abstract

PURPOSE: The Braden Scale is one of the most intensively studied risk assessment scales used in identifying the risk of developing pressure sore. However, not all studies show that the predictive validity of this scale is sufficient. The purpose of this study was to evaluate the Braden Scale for predicting pressure ulcer development.
METHODS: Articles published 1946 and 2013 from periodicals indexed in Ovid Medline, Embase, CINAHL, KoreaMed, NDSL and other databases were selected, using the following keywords: 'pressure ulcer'. The QUADAS-II was applied to assess the internal validity of the diagnostic studies. Selected studies were analyzed using meta-analysis with MetaDisc 1.4.
RESULTS: Thirty-eight diagnostic studies with high methodological quality, involving 17,934 patients, were included. Results of the meta-analysis showed that the pooled sensitivity and specificity of the Braden Scale were 0.74 (95% CI: 0.72-0.76), 0.75 (95% CI: 0.74-0.76) respectively. However the predictive validity of the Braden Scale has limitation because there was high heterogeneity between studies.
CONCLUSION: The Braden Scale's predictive validity of risk for pressure ulcer is interpreted as at a moderate level. However there is a limitation to the interpretation of the results, because of high heterogeneity among the studies.

Entities:  

Keywords:  Meta-analysis; Pressure sore; Sensitivity; Specificity

Mesh:

Year:  2014        PMID: 25608538     DOI: 10.4040/jkan.2014.44.6.595

Source DB:  PubMed          Journal:  J Korean Acad Nurs        ISSN: 2005-3673            Impact factor:   0.984


  1 in total

Review 1.  A prediction tool for hospital-acquired pressure ulcers among surgical patients: Surgical pressure ulcer risk score.

Authors:  Fazila Aloweni; Shin Yuh Ang; Stephanie Fook-Chong; Nurliyana Agus; Patricia Yong; Meh Meh Goh; Lisa Tucker-Kellogg; Rick Chai Soh
Journal:  Int Wound J       Date:  2018-10-05       Impact factor: 3.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.